Alphagan® P 0.1% : Patient - Request a Rebate

Request a rebate by providing the information below.

Print your rebate coupon after completing the form below. Only 1 rebate per customer. See additional terms and conditions below – coupon valid for commercial and cash-pay patients only.

*First name:

*Last name:

*E-mail:

*Address:

*City:

*State:

*Zip:

	I would like to receive future e-mail communications regarding information and special offers for ALPHAGAN^® P 0.1%.
	You may unsubscribe or update at any time.
	Read our Privacy Statement.

Offer not valid for prescriptions purchased under Medicare, Medicaid, certain similar federal or state programs, or where prohibited by law. Under certain state laws, you may need to disclose your acceptance of offers to your third-party payer (insurer). This rebate coupon must be accompanied by proof of purchase (pharmacy receipt), may not be reproduced, and must accompany this request. Proof of purchase will not be returned. Eligibility is restricted to individuals: no clubs, groups, or organizations. Offer good only in the USA. Void where taxed or restricted.

If you have already registered, but would like to print your rebate again, please click here.

Indication: ALPHAGAN^® P 0.1% ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Important Safety Information
Contraindication: ALPHAGAN^® P 0.1% is contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy.
Precautions: Although ALPHAGAN^® P 0.1% ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. ALPHAGAN^® P 0.1% should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans.
Adverse reactions: Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, conjunctival hyperemia, and eye pruritus. Adverse events occurring in approximately 5% to 9% included: burning sensation, conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness, and visual disturbance.

Please click here for full product information.